Master data| INID | Criterion | Field | Content |
|---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
| 21 | DE file number | DAKZ | 60 2018 040 448.1 |
| 96 | EP file number | EAKZ | 18 82 7841.0 |
| 86 | WO file number | WAKZ | PCT/CN2018/093965 |
| 97 | EP publication number | EPN | 3650444 |
| 87 | WO publication number | WPN | 2019007299 |
| 54 | Designation/title | TI | SALZ UND POLYMORPH EINER BENZOPYRIMIDINONVERBINDUNG UND PHARMAZEUTISCHE ZUSAMMENSETZUNG UND VERWENDUNG DAVON |
| 51 | IPC main class | ICM (ICMV) | C07D 239/32 (2006.01) |
| 51 | IPC secondary class(es) | ICS (ICSV) | C07D 239/36 (2006.01), A61P 15/10 (2006.01), A61K 31/506 (2006.01) |
| 22 | DE application date | DAT | Jul 2, 2018 |
| 96 | EP application date | EAT | Jul 2, 2018 |
| 86 | WO application date | WAT | Jul 2, 2018 |
| 43 | Date of first publication | OT | Jan 10, 2019 |
| Date of publication of grant | PET | Sep 7, 2022 |
| 71/73 | Applicant/owner | INH | Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, CN; Vigonvita Life Sciences Co., Ltd., Suzhou, Jiangsu, CN |
| 72 | Inventor | IN | SHEN, Jingshan, Pudong Shanghai 201203, CN; HE, Yang, Pudong Shanghai 201203, CN; CHEN, Weiming, Pudong Shanghai 201203, CN; LI, Jianfeng, Pudong Shanghai 201203, CN; TIAN, Guanghui, Suzhou Jiangsu 215123, CN; GONG, Xudong, Pudong Shanghai 201203, CN; WANG, Zhen, Pudong Shanghai 201203, CN; ZHANG, Rongxia, Pudong Shanghai 201203, CN; LIU, Yongjian, Pudong Shanghai 201203, CN; JIANG, Hualiang, Pudong Shanghai 201203, CN |
| 74 | Representative | VTR | Viering, Jentschura & Partner mbB Patent- und Rechtsanwälte, 81675 München, DE |
| Address for service | | Viering, Jentschura & Partner mbB Patent- und Rechtsanwälte, 81675 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| CN 201710551480 Jul 7, 2017
|
| Due date | FT FG | Jul 31, 2026 Annual fee for the 9th year
Patent fees |
| Patent division in charge | | 44 |
| 97 | EP language of publication | ELANG | EN - Englisch |
| 84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003650444A1 Searchable text:
EP000003650444A1 Original document:
EP000003650444B1 Searchable text:
EP000003650444B1 Original document:
WO002019007299 Searchable text:
WO002019007299 |
| 43 | Date of first publication | EVT | Jan 10, 2019 |
| Date of the first transfer into DPMAregister | EREGT | May 12, 2020 |
| Date of the (most recent) update in DPMAregister | REGT | Aug 12, 2025 (Show all update days)(Hide all update days)- Aug 12, 2025
- Aug 7, 2025
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 07.09.2022: new
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 07.09.2022: deleted
- Jul 24, 2024
- Jun 6, 2024; Aug 3, 2023; Jul 20, 2023; Jul 14, 2023; Jul 4, 2023; Nov 19, 2022; Sep 22, 2022; Aug 18, 2022
- Historical data not available for this/these date(s)
- May 12, 2020
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 7)| INID | Criterion | Field | Content
Close details
|
|---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Jul 3, 2023 |
| Issue number | HN | 32 |
| Year | PJ | 2023 |
| Publication date | VT | Aug 10, 2023 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
| 71/73 | Applicant/owner | INH | Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, CN; Vigonvita Life Sciences Co., Ltd., Suzhou, Jiangsu, CN |
| 71/73 | Previous applicant/owner | INHF | Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, CN, Suzhou Vigonvita Life Sciences Co., Ltd., Suzhou, Jiangsu, CN, Topharman Shanghai Co., Ltd., Shanghai, CN |
| Date of update of the procedure | REGT | Jul 14, 2023 |